In conclusion, the ability of GoraVir to efficiently replicate in pancreatic cancer cell lines regardless of subsequent antiviral responses and to induce ICD irrespective of STING expression, seems illustrative of an interesting oncolytic candidate. This evidence concerns the gene STING1 and familial pancreatic carcinoma.